ATYPICAL PARKINSONISM
Clinical trials for ATYPICAL PARKINSONISM explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL PARKINSONISM trials appear
Sign up with your email to follow new studies for ATYPICAL PARKINSONISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a failed ALS drug help PSP patients? new trial results are in
Disease control CompletedThis completed Phase 2b/3 trial tested the drug AMX0035 in 139 people with progressive supranuclear palsy (PSP), a rare brain disease that causes problems with balance, movement, and thinking. The study compared the drug to a placebo to see if it could slow the disease. The resul…
Matched conditions: ATYPICAL PARKINSONISM
Phase: PHASE2, PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a One-Time bone drug shield Parkinson's patients from fractures?
Prevention CompletedThis study tested whether a single infusion of zoledronic acid (Reclast) can prevent fractures in men and women aged 60 and older with Parkinson's disease or related conditions. Over 2,700 participants were randomly assigned to receive either the drug or a placebo, and were follo…
Matched conditions: ATYPICAL PARKINSONISM
Phase: PHASE4 • Sponsor: California Pacific Medical Center Research Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC